25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

TITAN BIOTECH LTD.
Buy, Hold or Sell?

Let's analyze TITAN BIOTECH LTD. together

I guess you are interested in TITAN BIOTECH LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of TITAN BIOTECH LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about TITAN BIOTECH LTD.

I send you an email if I find something interesting about TITAN BIOTECH LTD..

1. Quick Overview

1.1. Quick analysis of TITAN BIOTECH LTD. (30 sec.)










1.2. What can you expect buying and holding a share of TITAN BIOTECH LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.09
When do you have the money?
1 year
How often do you get paid?
66.7%

What is your share worth?

Current worth
INR161.49
Expected worth in 1 year
INR275.44
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR121.15
Return On Investment
16.0%

For what price can you sell your share?

Current Price per Share
INR758.00
Expected price per share
INR645.00 - INR1,018
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of TITAN BIOTECH LTD. (5 min.)




Live pricePrice per Share (EOD)
INR758.00
Intrinsic Value Per Share
INR19.44 - INR189.44
Total Value Per Share
INR180.93 - INR350.93

2.2. Growth of TITAN BIOTECH LTD. (5 min.)




Is TITAN BIOTECH LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$15.8m$13m$2.8m17.6%

How much money is TITAN BIOTECH LTD. making?

Current yearPrevious yearGrowGrow %
Making money$2.9m$2.9m$1k0.0%
Net Profit Margin15.1%17.3%--

How much money comes from the company's main activities?

2.3. Financial Health of TITAN BIOTECH LTD. (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of TITAN BIOTECH LTD.?

Welcome investor! TITAN BIOTECH LTD.'s management wants to use your money to grow the business. In return you get a share of TITAN BIOTECH LTD..

First you should know what it really means to hold a share of TITAN BIOTECH LTD.. And how you can make/lose money.

Speculation

The Price per Share of TITAN BIOTECH LTD. is INR758.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of TITAN BIOTECH LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in TITAN BIOTECH LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR161.49. Based on the TTM, the Book Value Change Per Share is INR28.49 per quarter. Based on the YOY, the Book Value Change Per Share is INR28.64 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR1.80 per quarter.
Based on historical numbers we can estimate the returns while holding a share of TITAN BIOTECH LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.360.0%0.360.0%0.360.0%0.310.0%0.270.0%
Usd Book Value Change Per Share0.340.0%0.340.0%0.340.0%0.290.0%0.320.0%
Usd Dividend Per Share0.020.0%0.020.0%0.020.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.360.0%0.360.0%0.360.0%0.300.0%0.330.0%
Usd Price Per Share6.29-6.29-2.34-2.89-2.50-
Price to Earnings Ratio17.56-17.56-6.55-8.83-9.12-
Price-to-Total Gains Ratio17.44-17.44-6.53-9.55-8.14-
Price to Book Ratio3.27-3.27-1.48-2.05-1.89-
Price-to-Total Gains Ratio17.44-17.44-6.53-9.55-8.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share9.0202
Number of shares110
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.340.29
Usd Total Gains Per Share0.360.30
Gains per Quarter (110 shares)39.6533.10
Gains per Year (110 shares)158.58132.41
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
191491496126122
21929830812253254
32844746718379386
43859762624505518
54774678530632650
65789594436758782
7661044110343884914
875119312624910111046
985134214215511371178
1094149215806112631310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%4.00.01.080.0%4.00.02.066.7%4.00.02.066.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of TITAN BIOTECH LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--28.48728.4870%28.639-1%24.128+18%26.915+6%
Book Value Per Share--161.491161.4910%133.004+21%107.368+50%96.281+68%
Current Ratio--3.7743.7740%3.356+12%3.221+17%3.056+24%
Debt To Asset Ratio--0.1480.1480%0.183-19%0.253-42%0.291-49%
Debt To Equity Ratio--0.1730.1730%0.224-23%0.388-55%0.484-64%
Dividend Per Share--1.8001.8000%1.500+20%1.160+55%0.967+86%
Eps--30.07530.0750%30.064+0%26.328+14%22.650+33%
Free Cash Flow Per Share--14.70014.7000%0.870+1590%8.050+83%6.914+113%
Free Cash Flow To Equity Per Share--14.70014.7000%0.870+1590%7.095+107%6.073+142%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--189.440--------
Intrinsic Value_10Y_min--19.442--------
Intrinsic Value_1Y_max--10.431--------
Intrinsic Value_1Y_min--5.659--------
Intrinsic Value_3Y_max--37.858--------
Intrinsic Value_3Y_min--13.890--------
Intrinsic Value_5Y_max--73.144--------
Intrinsic Value_5Y_min--18.646--------
Market Cap--4364886340.0004364886340.0000%1626709345.000+168%2008574922.000+117%1735790185.000+151%
Net Profit Margin--0.1510.1510%0.173-12%0.160-6%0.143+6%
Operating Margin----0%-0%0.029-100%0.043-100%
Operating Ratio--1.2721.2720%1.298-2%1.315-3%1.348-6%
Pb Ratio4.694+30%3.2713.2710%1.480+121%2.045+60%1.888+73%
Pe Ratio25.204+30%17.56317.5630%6.548+168%8.828+99%9.116+93%
Price Per Share758.000+30%528.200528.2000%196.850+168%243.060+117%210.050+151%
Price To Free Cash Flow Ratio51.564+30%35.93135.9310%226.341-84%68.590-48%63.239-43%
Price To Total Gains Ratio25.028+30%17.44017.4400%6.531+167%9.551+83%8.143+114%
Quick Ratio--0.9760.9760%1.032-5%0.901+8%0.850+15%
Return On Assets--0.1590.1590%0.185-14%0.188-15%0.165-4%
Return On Equity--0.1860.1860%0.226-18%0.257-28%0.232-20%
Total Gains Per Share--30.28730.2870%30.139+0%25.288+20%27.882+9%
Usd Book Value--15880692.80015880692.8000%13079373.300+21%10558324.056+50%9468132.607+68%
Usd Book Value Change Per Share--0.3390.3390%0.341-1%0.287+18%0.320+6%
Usd Book Value Per Share--1.9221.9220%1.583+21%1.278+50%1.146+68%
Usd Dividend Per Share--0.0210.0210%0.018+20%0.014+55%0.012+86%
Usd Eps--0.3580.3580%0.358+0%0.313+14%0.270+33%
Usd Free Cash Flow--1445600.1001445600.1000%85525.300+1590%791658.116+83%679930.854+113%
Usd Free Cash Flow Per Share--0.1750.1750%0.010+1590%0.096+83%0.082+113%
Usd Free Cash Flow To Equity Per Share--0.1750.1750%0.010+1590%0.084+107%0.072+142%
Usd Market Cap--51942147.44651942147.4460%19357841.206+168%23902041.572+117%20655903.202+151%
Usd Price Per Share9.020+30%6.2866.2860%2.343+168%2.892+117%2.500+151%
Usd Profit--2957507.0002957507.0000%2956459.800+0%2589023.149+14%2227378.445+33%
Usd Revenue--19524579.90019524579.9000%17135916.700+14%15548432.611+26%14244369.831+37%
Usd Total Gains Per Share--0.3600.3600%0.359+0%0.301+20%0.332+9%
 EOD+2 -4MRQTTM+0 -0YOY+25 -95Y+28 -710Y+29 -6

3.3 Fundamental Score

Let's check the fundamental score of TITAN BIOTECH LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1525.204
Price to Book Ratio (EOD)Between0-14.694
Net Profit Margin (MRQ)Greater than00.151
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.976
Current Ratio (MRQ)Greater than13.774
Debt to Asset Ratio (MRQ)Less than10.148
Debt to Equity Ratio (MRQ)Less than10.173
Return on Equity (MRQ)Greater than0.150.186
Return on Assets (MRQ)Greater than0.050.159
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of TITAN BIOTECH LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.878
Ma 20Greater thanMa 50833.193
Ma 50Greater thanMa 100806.089
Ma 100Greater thanMa 200702.823
OpenGreater thanClose759.050
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About TITAN BIOTECH LTD.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit TITAN BIOTECH LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare TITAN BIOTECH LTD. to the  industry mean.
  • A Net Profit Margin of 15.1% means that ₹0.15 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of TITAN BIOTECH LTD.:

  • The MRQ is 15.1%. The company is making a huge profit. +2
  • The TTM is 15.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.1%TTM15.1%0.0%
TTM15.1%YOY17.3%-2.1%
TTM15.1%5Y16.0%-0.9%
5Y16.0%10Y14.3%+1.8%
4.3.1.2. Return on Assets

Shows how efficient TITAN BIOTECH LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare TITAN BIOTECH LTD. to the  industry mean.
  • 15.9% Return on Assets means that TITAN BIOTECH LTD. generated ₹0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of TITAN BIOTECH LTD.:

  • The MRQ is 15.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 15.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ15.9%TTM15.9%0.0%
TTM15.9%YOY18.5%-2.6%
TTM15.9%5Y18.8%-2.9%
5Y18.8%10Y16.5%+2.2%
4.3.1.3. Return on Equity

Shows how efficient TITAN BIOTECH LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare TITAN BIOTECH LTD. to the  industry mean.
  • 18.6% Return on Equity means TITAN BIOTECH LTD. generated ₹0.19 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of TITAN BIOTECH LTD.:

  • The MRQ is 18.6%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 18.6%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ18.6%TTM18.6%0.0%
TTM18.6%YOY22.6%-4.0%
TTM18.6%5Y25.7%-7.1%
5Y25.7%10Y23.2%+2.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of TITAN BIOTECH LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient TITAN BIOTECH LTD. is operating .

  • Measures how much profit TITAN BIOTECH LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare TITAN BIOTECH LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of TITAN BIOTECH LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.9%-2.9%
5Y2.9%10Y4.3%-1.4%
4.3.2.2. Operating Ratio

Measures how efficient TITAN BIOTECH LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.27 means that the operating costs are ₹1.27 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of TITAN BIOTECH LTD.:

  • The MRQ is 1.272. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.272. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.272TTM1.2720.000
TTM1.272YOY1.298-0.026
TTM1.2725Y1.315-0.043
5Y1.31510Y1.348-0.032
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of TITAN BIOTECH LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if TITAN BIOTECH LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 3.77 means the company has ₹3.77 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of TITAN BIOTECH LTD.:

  • The MRQ is 3.774. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.774. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.774TTM3.7740.000
TTM3.774YOY3.356+0.417
TTM3.7745Y3.221+0.552
5Y3.22110Y3.056+0.166
4.4.3.2. Quick Ratio

Measures if TITAN BIOTECH LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare TITAN BIOTECH LTD. to the  industry mean.
  • A Quick Ratio of 0.98 means the company can pay off ₹0.98 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of TITAN BIOTECH LTD.:

  • The MRQ is 0.976. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.976. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.976TTM0.9760.000
TTM0.976YOY1.032-0.057
TTM0.9765Y0.901+0.075
5Y0.90110Y0.850+0.051
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of TITAN BIOTECH LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of TITAN BIOTECH LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare TITAN BIOTECH LTD. to industry mean.
  • A Debt to Asset Ratio of 0.15 means that TITAN BIOTECH LTD. assets are financed with 14.8% credit (debt) and the remaining percentage (100% - 14.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of TITAN BIOTECH LTD.:

  • The MRQ is 0.148. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.148. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.148TTM0.1480.000
TTM0.148YOY0.183-0.035
TTM0.1485Y0.253-0.106
5Y0.25310Y0.291-0.038
4.5.4.2. Debt to Equity Ratio

Measures if TITAN BIOTECH LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare TITAN BIOTECH LTD. to the  industry mean.
  • A Debt to Equity ratio of 17.3% means that company has ₹0.17 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of TITAN BIOTECH LTD.:

  • The MRQ is 0.173. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.173. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.173TTM0.1730.000
TTM0.173YOY0.224-0.051
TTM0.1735Y0.388-0.215
5Y0.38810Y0.484-0.096
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings TITAN BIOTECH LTD. generates.

  • Above 15 is considered overpriced but always compare TITAN BIOTECH LTD. to the  industry mean.
  • A PE ratio of 17.56 means the investor is paying ₹17.56 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of TITAN BIOTECH LTD.:

  • The EOD is 25.204. Based on the earnings, the company is overpriced. -1
  • The MRQ is 17.563. Based on the earnings, the company is fair priced.
  • The TTM is 17.563. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD25.204MRQ17.563+7.641
MRQ17.563TTM17.5630.000
TTM17.563YOY6.548+11.015
TTM17.5635Y8.828+8.735
5Y8.82810Y9.116-0.288
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of TITAN BIOTECH LTD.:

  • The EOD is 51.564. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 35.931. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 35.931. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD51.564MRQ35.931+15.632
MRQ35.931TTM35.9310.000
TTM35.931YOY226.341-190.409
TTM35.9315Y68.590-32.659
5Y68.59010Y63.239+5.351
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of TITAN BIOTECH LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 3.27 means the investor is paying ₹3.27 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of TITAN BIOTECH LTD.:

  • The EOD is 4.694. Based on the equity, the company is fair priced.
  • The MRQ is 3.271. Based on the equity, the company is fair priced.
  • The TTM is 3.271. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.694MRQ3.271+1.423
MRQ3.271TTM3.2710.000
TTM3.271YOY1.480+1.791
TTM3.2715Y2.045+1.226
5Y2.04510Y1.888+0.157
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets1,565,799
Total Liabilities231,287
Total Stockholder Equity1,334,512
 As reported
Total Liabilities 231,287
Total Stockholder Equity+ 1,334,512
Total Assets = 1,565,799

Assets

Total Assets1,565,799
Total Current Assets721,741
Long-term Assets844,058
Total Current Assets
Cash And Cash Equivalents 28,401
Net Receivables 186,579
Inventory 455,710
Other Current Assets 50,523
Total Current Assets  (as reported)721,741
Total Current Assets  (calculated)721,213
+/- 528
Long-term Assets
Property Plant Equipment 544,697
Intangible Assets 950
Long-term Assets  (as reported)844,058
Long-term Assets  (calculated)545,647
+/- 298,411

Liabilities & Shareholders' Equity

Total Current Liabilities191,252
Long-term Liabilities40,035
Total Stockholder Equity1,334,512
Total Current Liabilities
Short Long Term Debt 67,176
Accounts payable 33,682
Other Current Liabilities 23,881
Total Current Liabilities  (as reported)191,252
Total Current Liabilities  (calculated)124,739
+/- 66,513
Long-term Liabilities
Long term Debt 4,533
Capital Lease Obligations Min Short Term Debt11,320
Long-term Liabilities  (as reported)40,035
Long-term Liabilities  (calculated)15,853
+/- 24,182
Total Stockholder Equity
Total Stockholder Equity (as reported)1,334,512
Total Stockholder Equity (calculated)0
+/- 1,334,512
Other
Capital Stock82,637
Common Stock Shares Outstanding 8,264
Net Debt 43,308
Net Invested Capital 1,406,221
Net Working Capital 530,489
Property Plant and Equipment Gross 544,697



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
647,297
760,396
1,007,156
1,080,914
1,345,150
1,565,799
1,565,7991,345,1501,080,9141,007,156760,396647,29700
   > Total Current Assets 
295,382
292,721
351,351
441,979
588,264
637,558
683,056
721,741
721,741683,056637,558588,264441,979351,351292,721295,382
       Cash And Cash Equivalents 
0
0
18,748
18,327
54,506
68,139
48,637
28,401
28,40148,63768,13954,50618,32718,74800
       Short-term Investments 
0
0
1,613
246
1,839
0
0
0
0001,8392461,61300
       Net Receivables 
77,875
77,745
92,431
118,625
181,038
163,591
210,077
186,579
186,579210,077163,591181,038118,62592,43177,74577,875
       Inventory 
144,993
175,832
211,332
279,758
325,377
346,797
365,577
455,710
455,710365,577346,797325,377279,758211,332175,832144,993
       Other Current Assets 
29,881
30,981
28,301
24,243
27,343
59,031
43,227
50,523
50,52343,22759,03127,34324,24328,30130,98129,881
   > Long-term Assets 
0
0
295,946
318,417
418,892
443,356
662,095
844,058
844,058662,095443,356418,892318,417295,94600
       Property Plant Equipment 
219,360
268,031
289,241
311,286
337,854
385,145
491,035
544,697
544,697491,035385,145337,854311,286289,241268,031219,360
       Intangible Assets 
0
0
942
1,009
917
1,045
852
950
9508521,0459171,00994200
       Long-term Assets Other 
0
0
60
30
0
1,140
1
0
011,1400306000
> Total Liabilities 
0
0
309,720
344,946
282,395
218,473
246,043
231,287
231,287246,043218,473282,395344,946309,72000
   > Total Current Liabilities 
122,525
110,122
157,775
204,298
192,796
169,494
203,506
191,252
191,252203,506169,494192,796204,298157,775110,122122,525
       Short Long Term Debt 
0
0
104,837
123,212
82,853
64,501
66,996
67,176
67,17666,99664,50182,853123,212104,83700
       Accounts payable 
14,022
10,873
21,449
41,238
37,135
41,599
55,497
33,682
33,68255,49741,59937,13541,23821,44910,87314,022
       Other Current Liabilities 
26,340
3,498
11,468
17,356
17,933
17,483
24,284
23,881
23,88124,28417,48317,93317,35611,4683,49826,340
   > Long-term Liabilities 
0
0
151,945
140,648
89,599
48,979
42,537
40,035
40,03542,53748,97989,599140,648151,94500
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
16,485
13,983
15,132
11,320
11,32015,13213,98316,4850000
       Long-term Liabilities Other 
0
0
0
0
0
0
1
0
01000000
       Deferred Long Term Liability 
119
89
60
30
0
0
0
0
0000306089119
> Total Stockholder Equity
0
0
321,763
391,933
687,582
862,441
1,099,107
1,334,512
1,334,5121,099,107862,441687,582391,933321,76300
   Common Stock
77,387
77,387
82,637
82,637
0
0
0
0
000082,63782,63777,38777,387
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
0
135
1,105
617
0
0
0
0
00006171,1051350



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,640,721
Cost of Revenue-756,061
Gross Profit884,660884,660
 
Operating Income (+$)
Gross Profit884,660
Operating Expense-1,331,213
Operating Income309,508-446,553
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense1,331,2130
 
Net Interest Income (+$)
Interest Income0
Interest Expense-11,700
Other Finance Cost-0
Net Interest Income-11,700
 
Pretax Income (+$)
Operating Income309,508
Net Interest Income-11,700
Other Non-Operating Income Expenses0
Income Before Tax (EBT)315,290309,508
EBIT - interestExpense = -11,700
248,530
260,230
Interest Expense11,700
Earnings Before Interest and Taxes (EBIT)0326,990
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax315,290
Tax Provision-78,658
Net Income From Continuing Ops248,530236,632
Net Income248,530
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net011,700
 

Technical Analysis of TITAN BIOTECH LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of TITAN BIOTECH LTD.. The general trend of TITAN BIOTECH LTD. is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine TITAN BIOTECH LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of TITAN BIOTECH LTD..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 808.50 < 1,018.

The bearish price targets are: 745.00 > 654.25 > 645.00.

Tweet this
TITAN BIOTECH LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of TITAN BIOTECH LTD.. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

TITAN BIOTECH LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of TITAN BIOTECH LTD.. The current macd is -20.54995537.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the TITAN BIOTECH LTD. price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for TITAN BIOTECH LTD.. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the TITAN BIOTECH LTD. price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
TITAN BIOTECH LTD. Daily Moving Average Convergence/Divergence (MACD) ChartTITAN BIOTECH LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of TITAN BIOTECH LTD.. The current adx is 19.30.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell TITAN BIOTECH LTD. shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
TITAN BIOTECH LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of TITAN BIOTECH LTD.. The current sar is 835.62.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
TITAN BIOTECH LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of TITAN BIOTECH LTD.. The current rsi is 38.88. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
TITAN BIOTECH LTD. Daily Relative Strength Index (RSI) ChartTITAN BIOTECH LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of TITAN BIOTECH LTD.. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the TITAN BIOTECH LTD. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
TITAN BIOTECH LTD. Daily Stochastic Oscillator ChartTITAN BIOTECH LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of TITAN BIOTECH LTD.. The current cci is -76.233009.

TITAN BIOTECH LTD. Daily Commodity Channel Index (CCI) ChartTITAN BIOTECH LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of TITAN BIOTECH LTD.. The current cmo is -35.20297736.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
TITAN BIOTECH LTD. Daily Chande Momentum Oscillator (CMO) ChartTITAN BIOTECH LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of TITAN BIOTECH LTD.. The current willr is -85.18518519.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
TITAN BIOTECH LTD. Daily Williams %R ChartTITAN BIOTECH LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of TITAN BIOTECH LTD..

TITAN BIOTECH LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of TITAN BIOTECH LTD.. The current atr is 50.60.

TITAN BIOTECH LTD. Daily Average True Range (ATR) ChartTITAN BIOTECH LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of TITAN BIOTECH LTD.. The current obv is 1,078,924.

TITAN BIOTECH LTD. Daily On-Balance Volume (OBV) ChartTITAN BIOTECH LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of TITAN BIOTECH LTD.. The current mfi is 22.63.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
TITAN BIOTECH LTD. Daily Money Flow Index (MFI) ChartTITAN BIOTECH LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for TITAN BIOTECH LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-17MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

TITAN BIOTECH LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of TITAN BIOTECH LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.878
Ma 20Greater thanMa 50833.193
Ma 50Greater thanMa 100806.089
Ma 100Greater thanMa 200702.823
OpenGreater thanClose759.050
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of TITAN BIOTECH LTD. with someone you think should read this too:
  • Are you bullish or bearish on TITAN BIOTECH LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about TITAN BIOTECH LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about TITAN BIOTECH LTD.

I send you an email if I find something interesting about TITAN BIOTECH LTD..


Comments

How you think about this?

Leave a comment

Stay informed about TITAN BIOTECH LTD..

Receive notifications about TITAN BIOTECH LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.